Aldara review

Aldara, which is generically prescribed as imiquimod topical, is commonly used to treat variations of genital warts, perianal warts and warty overgrowths which occur on the face, scalp, or neck which are known as actinic warts. Aldara is also used in the treatment of superficial basal cell carcinoma.

Aldara is not for everyone. A thorough medical history should be assessed prior to prescribing this medication. Patients with a medical history which includes open sores, unhealed lesions, burns, or wounds, or a history which includes a sensitivity to imiquimod topical creams may not be able to use Aldara, or may require careful monitoring while undergoing drug therapy with this medication, depending on the condition and the severity of the condition.

The American Food and Drug Administration rated Aldara as a pregnancy risk category C. It has yet to be determined whether or not Aldara will cause harm or birth defects to an unborn baby. It has yet to be determined whether or not this medication passes through the mother’s breast milk and harms a nursing baby. The prescribing physician should avoid prescribing this medication to women who are pregnant, nursing, or have a likelihood of becoming pregnant.

There is a risk of side effects associated with Aldara, some of which are severe. A patient who is experiencing a serious side effect or an allergic reaction should seek immediate emergency medical attention. An allergic reaction will present with symptoms such as facial swelling, including swelling of the lips, mouth, tongue, or throat, hives, and difficulty breathing. Other serious side effects which require emergency medical attention include symptoms such as burning of the skin, severe rash, and skin blistering, although these symptoms are very rare.

Other less serious side effects typically do not require emergency medical attention but should be reported to the prescribing physician. Patients should be encouraged to report all side effects. Less serious side effects include symptoms which include reactions at the site of treatment including swelling, sores, blisters, ulcers, skin hardening, scabbing, crusting, and itching, tolerable burning, skin color alterations that may or may not go away, headaches, diarrhea, muscle aches, and fatigue. Less serious side effects can often be reduced to a tolerable level by reducing the dosage of Aldara.

Aldara should be applied exactly as it has been prescribed by the physician. If the patient misses a dose, the dose should be applied as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to avoid the potential for an overdose. The patient should never double up their application of this medication. If an overdose is suspected, the patient should seek immediate emergency medical treatment. Symptoms of an overdose may present with symptoms which include sever skin reactions such as intolerable burning, swelling, redness, and painful peeling, and possible systemic reactions such as low blood pressure.

There is a risk of negative drug interactions associated with Aldara. A thorough medical history should be understood prior to prescribing this medication. Patients should be urged to inquire with the prescribing physician before taking any new medications, including over the counter medication and herbal remedies. Medications with known negative interactions with Aldara include other topical medications to treat warts, itch, or skin discomfort, although the chance of interaction is small.

Aldara has the following structural formula:

Chemical structure of aldara

• Molecular formula of aldara is C14H16N4
• Molecular weight is 240.304 g/mol
Aldara available : 12 5% cream

Generic name: Imiquimod topical

  Your Aldara review